8-A12B
 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-A
 
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR 12(g) OF THE
SECURITIES EXCHANGE ACT OF 1934
 
AMICUS THERAPEUTICS, INC.
(Exact name of registrant as specified in its charter)
 
     
Delaware
 
(State of incorporation or
organization) 		  20-0422823
 
(I.R.S. Employer Identification No.)
6 Cedar Brook Drive, Cranbury, NJ 08512
 
(Address of principal executive offices)    (Zip Code)
 
Securities to be registered pursuant to Section 12(b) of the Act:
         
  Title of each class
to be so registered		   Name of each exchange on which
each class is to be registered		  
 
  Common Stock, $0.01 par value   The NASDAQ Stock Market LLC  
 
         
  If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c), please check the following box.  þ   If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d), please check the following box.  o  
Securities Act registration statement file number to which this form relates:    File No. 333-141700
(if applicable)
 
(Title of Class)                       

 

 

ITEM 1.  DESCRIPTION OF REGISTRANT’S SECURITIES TO BE REGISTERED.
     See the “Description of Capital Stock” section in the prospectus included in the Registration Statement on Form S-1 (File No. 333-141700) of Amicus Therapeutics, Inc. (the “Registrant”), initially filed with the Securities and Exchange Commission on March 30, 2007, including any subsequent amendments thereto, which section is hereby incorporated by reference herein.
ITEM 2.  EXHIBITS.
     Under the Instructions as to Exhibits with respect to Form 8-A, no exhibits are required to be filed because no other securities of the Registrant are registered on The NASDAQ Stock Market LLC and the securities registered hereby are not being registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended.

 

 

SIGNATURES
     Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the Registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized.
         
  AMICUS THERAPEUTICS, INC.
 
 
  
  By:   /s/  Douglas A. Branch  
    Douglas A. Branch, Esq.
Vice President and General Counsel
    
Date:  May 23, 2007